Large CDMO Lonza to build a new large-scale, commercial drug product facility including fill and finish to support customers across the entire product life cycle in Switzerland, investment of CHF500m.
Lee Patterson joins UK-based Charnwood Molecular as new CEO. After nearly 25 years at UK-based Charnwood Molecular, Prof. Steve Allin has stepping down as CEO. He will remain as an investor and Board advisor.
https://european-biotechnology.com/wp-content/uploads/2024/04/Lee_Patterson_CML_kl-scaled.jpg25602278Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2022-07-06 10:58:002024-07-16 17:54:15Charnwood Molecular with new CEO
French drugmaker Pierre Fabre Médicaments will pay $75m for an exclusive licence to to commercialise Urovant Sciences’ drug vibegron for the treatment of overactive bladder in Europe.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2022-07-05_um_23.33.42.png8811297Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-07-05 17:10:002024-04-04 16:46:30Urovant Sciences cashes in $75m in licence deal from Pierre Fabre
At the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth €50,000.
https://european-biotechnology.com/wp-content/uploads/2024/04/BioNTainers.jpg4561140Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-06-23 12:31:122024-04-04 16:46:33BIONTech breaks ground for manufacturing site in Rwanda
In an effort to become a major player in Europe’s growing pharmaceutical-grade cannabis market, Danish Canify AS and Bavaria Weed GmbH merge to form Canify AG.
https://european-biotechnology.com/wp-content/uploads/2024/04/Canify.PNG481889Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-06-22 12:06:302024-04-04 16:46:33Cannabis players Canify AS and Bavaria Weed merge to form Canify AG
Lonza invests CHF500m in Large-Scale Facility in Stein (CH)
Latest NewsLarge CDMO Lonza to build a new large-scale, commercial drug product facility including fill and finish to support customers across the entire product life cycle in Switzerland, investment of CHF500m.
Charnwood Molecular with new CEO
AppointmentsLee Patterson joins UK-based Charnwood Molecular as new CEO. After nearly 25 years at UK-based Charnwood Molecular, Prof. Steve Allin has stepping down as CEO. He will remain as an investor and Board advisor.
Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
Latest NewsEvotec, pharma giant Boehringer Ingelheim, and IVD specialist bioMérieux have launched a €40m joint venture to fight Antimicrobial Resistance (AMR).
Urovant Sciences cashes in $75m in licence deal from Pierre Fabre
Latest NewsFrench drugmaker Pierre Fabre Médicaments will pay $75m for an exclusive licence to to commercialise Urovant Sciences’ drug vibegron for the treatment of overactive bladder in Europe.
CureVac NV sues BioNTech for IP infringement
Latest NewsGerman mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued BioNTech/Pfizer for infringement of four patents.
French Ipsen falls after Epizyme take-over announcement
Latest NewsShares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US cancer specialist Epizyme Inc. for $247m.
TWB announces winners in industrial biotech start-up contest
Latest NewsAt the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth €50,000.
BIONTech breaks ground for manufacturing site in Rwanda
Latest NewsBioNTech SE has announced it is going to ship the first containers for mRNA malaria vaccine production from this year’s end toKigall.
Cannabis players Canify AS and Bavaria Weed merge to form Canify AG
Latest NewsIn an effort to become a major player in Europe’s growing pharmaceutical-grade cannabis market, Danish Canify AS and Bavaria Weed GmbH merge to form Canify AG.
Unilever launches $120m venture with Genomatica
Latest NewsUnder the $120m deal, Genomatica and Unilever will scale plant- and waste-based alternative to palm oil and fossil fuels.